Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein
about
Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic RetinopathyThe Emerging Role of Thioredoxin-Interacting Protein in Myocardial Ischemia/Reperfusion InjuryMetabolic Remodeling in Diabetic Cardiomyopathy.Hyperglycemic and hyperlipidemic conditions alter cardiac cell biomechanical propertiesMinireview: Thioredoxin-interacting protein: regulation and function in the pancreatic β-cell.3',4'-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 ratsNod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemiaAzelnidipine protects myocardium in hyperglycemia-induced cardiac damageThe emerging role of the thioredoxin system in angiogenesisDeletion of thioredoxin interacting protein (TXNIP) augments hyperoxia-induced vaso-obliteration in a mouse model of oxygen induced-retinopathy.Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?Ginsenoside Rg1 ameliorates oxidative stress and myocardial apoptosis in streptozotocin-induced diabetic rats.Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus.Preventing β-cell loss and diabetes with calcium channel blockersSubtle renal dysfunction and bleeding risk in atrial fibrillation: symmetric dimethylarginine predicts HAS-BLED scoreCalcium channel blockers act through nuclear factor Y to control transcription of key cardiac genes.Protective effect of pioglitazone on cardiomyocyte apoptosis in low-dose streptozotocin & high-fat diet-induced type-2 diabetes in ratsThioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS studyTXNIP regulates myocardial fatty acid oxidation via miR-33a signalingDiabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management.Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia/reperfusion injury: role of thioredoxin-interacting protein.TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells.Thioredoxin-interacting protein stimulates its own expression via a positive feedback loop.Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms.Thioredoxin-interacting protein and myocardial mitochondrial function in ischemia-reperfusion injury.Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes.Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit.Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity.TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook.Emerging drugs for the treatment of angina pectoris.Carbamylated erythropoietin attenuates cardiomyopathy via PI3K/Akt activation in rats with diabetic cardiomyopathy.Thioredoxin-interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice.Neurovascular protective effect of FeTPPs in N-methyl-D-aspartate model: similarities to diabetes.Knockdown of thioredoxin interacting protein attenuates high glucose-induced apoptosis and activation of ASK1 in mouse mesangial cells.Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies.Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP.The Function of Thioredoxin-Binding Protein-2 (TBP-2) in Different Diseases.
P2860
Q28393006-29F9CADE-5D09-4F55-A530-11F874ED4746Q33559046-79F44DEB-6661-4482-90D9-FEA886F7F2D6Q33623469-AFD0FE18-9F47-4016-B574-F1AA358CE370Q33736504-CD13081C-8719-4E3E-9E32-A2972D391069Q33977405-229CD86C-8F28-44F3-B795-543244834056Q33987863-D5110B2E-9540-438D-9C08-32A65FAD1888Q34245112-313673EF-97D4-4524-A21D-7D5A8C45449DQ34419049-491D0433-C6D3-4806-9C54-6E6C57521E55Q35123800-2CEF2B6D-5CE6-4B1E-9F5F-C4C67A0786EEQ35348072-0734D9BD-B805-4F1E-98A8-14F65C62C696Q35486035-C26CCB39-927C-4449-8E0A-300130C59878Q35610092-ED619187-0E66-4271-991A-F05EC4311B40Q35634417-72160A09-D095-4839-95D0-AED31E1BC5F8Q35857734-F6959CE5-D62E-4DC5-9F54-7FCEF7BE1C6BQ35962795-DC7D965F-F6E3-4AF7-88B9-EDF1032EF61EQ36174757-508474B7-B638-4BCD-8817-9AC91285375EQ36550203-F91C8F29-2D6C-4712-ABC2-763FC89DE139Q36629722-12A345C2-2BF6-4085-91A8-2B4C17F61947Q36952295-0EB666CC-B6AE-4BCE-899F-7F0C966714F8Q37139649-EB5244C3-15D3-4E3A-8B35-E2FE7974067DQ37232675-430AAEFA-99D2-4CB6-8A7B-21A842E8DFC3Q37295345-680165BE-DC62-4069-924E-2D463725D405Q37330560-C976692F-78B8-4C5B-A165-316C1F9C9EDCQ37732578-432FEC73-B8A8-4C05-9D46-57E34D1C8D1EQ37935006-9A2A6F62-549E-466D-BC37-7A1BB32457D7Q38124617-4F316A39-B763-4708-93C9-85474D39EBBCQ38236593-2B9E70CD-6758-4997-ACC6-B7FB17D32BA3Q38256054-3CA33AAB-FE3A-4662-BD46-A737CD054FD4Q38387172-B1DE627E-15EA-48C4-8B53-787BACB3F209Q38764267-3FC9861D-3507-41D5-B0B3-C5BB45BD50B1Q38967994-F7ECE121-6225-4DBF-8997-6695337B9C0AQ41773498-7C06727A-041B-43B5-AC66-0BB5E444D446Q41812060-68F30B8B-D4D4-48AF-B517-24B11312FCA0Q42470643-D10D56E6-567C-4A9D-83D5-B93E0730FBE5Q44014285-D65627C2-8E59-471E-8A80-1605DD2768F0Q46880204-89D1F830-7F69-45A0-8B10-BE056B7F354AQ50437302-6246C1BD-F99E-4E40-98DD-B5C7929D0C03Q51002471-4EED923A-EE23-4528-9F3D-A6E077978191Q52709221-9C48975E-3CCB-4A08-B0B5-ACC294BD838AQ55185836-B3715EC4-9346-4A95-B88B-2D3EE626CBCB
P2860
Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diabetes induces and calcium c ...... hioredoxin-interacting protein
@en
Diabetes induces and calcium c ...... ioredoxin-interacting protein.
@nl
type
label
Diabetes induces and calcium c ...... hioredoxin-interacting protein
@en
Diabetes induces and calcium c ...... ioredoxin-interacting protein.
@nl
prefLabel
Diabetes induces and calcium c ...... hioredoxin-interacting protein
@en
Diabetes induces and calcium c ...... ioredoxin-interacting protein.
@nl
P2093
P2860
P1476
Diabetes induces and calcium c ...... hioredoxin-interacting protein
@en
P2093
Anath Shalev
Anna Szabo
Hyunjoo Cha-Molstad
Junqin Chen
P2860
P304
P356
10.1152/AJPENDO.90944.2008
P577
2009-03-03T00:00:00Z